Director, Value & Evidence – Hematology Oncology

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow.

Learn more at

Market Access

Health Economics Outcomes Research

People Leader

Horsham, Pennsylvania, United States of America

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to find treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at

Director, Real World Value & Evidence (RWV&E), US Medical Affairs, Hematology, to be located in Horsham, PA.

The Director, Real World Value & Evidence (RWV&E), US Medical Affairs, Hematology‑Oncology will be responsible for leading and implementing the economic modeling strategy, real‑world evidence generation strategy, market access & pathway scientific strategy, and dissemination plans for J&J’s Hematology portfolio.

• Ensure economic modeling, real world evidence and market access scientific support requirements are understood and built-in to the US business plans with value propositions that reflect the needs of payer stakeholders, population health decision makers, pathway decision makers and lead scientific strategic planning for RWV&E activities to enable access for the hematology portfolio.
• Hematology portfolio RWV&E activities this role is held accountable for include but are not limited to: development and governance of economic models across the hematology portfolio and ensuring consistency and methodological alignment across multiple assets. In close collaboration with RWV&E product leads, this role supports the generation of portfolio-level and asset-specific economic models to support payer, pathway and other population health decision makers access strategy.
• In addition, the role leads core RWV&E activities for the hematology portfolio including identifying and prioritizing key research and analytical questions, shaping evidence generation strategy, designing and overseeing studies, conducting market access analytics, managing publications, and developing compliant communication materials (e.g. Evidence & Access decks), and partnering with MSL/RWV&E FIELD to ensure effective and compliant communication.
• Ensures projects and economic models are aligned to the Integrated Evidence Generation Plan (IEGP) and business needs and executed on time
• Collaborate with internal and external experts to develop economic models, prioritize and generate rigorous scientific data, and develop dissemination plans to support the therapeutic area's IEGP
• Ensures compliance with regulatory, legal and commercial regulations (for example Contract Pricing Committee, Copy Approval Committee) in conducting research and dissemination of scientific and economic modeling information
• Collaborate with cross-functional business partners and alliance partners on scientific strategies and economic modeling strategies to support market access for our products
• Directly initiate and manage economic models, research studies and other related projects
• Serve as subject matter, and functional area expert in responding to U.S-focused Value Assessments of our hematology products by external organizations
• Ensure quality of design, execution, and publication of economic models and real-world evidence studies
• Dev…